BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28816351)

  • 1. Recent advances in genomic profiling of adenosquamous carcinoma of the pancreas.
    Marcus R; Maitra A; Roszik J
    J Pathol; 2017 Nov; 243(3):271-272. PubMed ID: 28816351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic signatures of pancreatic adenosquamous carcinoma (PASC).
    Fang Y; Su Z; Xie J; Xue R; Ma Q; Li Y; Zhao Y; Song Z; Lu X; Li H; Peng C; Bai F; Shen B
    J Pathol; 2017 Oct; 243(2):155-159. PubMed ID: 28722109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas.
    Lenkiewicz E; Malasi S; Hogenson TL; Flores LF; Barham W; Phillips WJ; Roesler AS; Chambers KR; Rajbhandari N; Hayashi A; Antal CE; Downes M; Grandgenett PM; Hollingsworth MA; Cridebring D; Xiong Y; Lee JH; Ye Z; Yan H; Hernandez MC; Leiting JL; Evans RM; Ordog T; Truty MJ; Borad MJ; Reya T; Von Hoff DD; Fernandez-Zapico ME; Barrett MT
    Cancer Res; 2020 Oct; 80(20):4324-4334. PubMed ID: 32928922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets.
    Silvestris N; Brunetti O; Pinto R; Petriella D; Argentiero A; Fucci L; Tommasi S; Danza K; De Summa S
    Expert Opin Ther Targets; 2018 May; 22(5):453-461. PubMed ID: 29561217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreas.
    Skorupan N; Ahmad MI; Steinberg SM; Trepel JB; Cridebring D; Han H; Von Hoff DD; Alewine C
    Future Oncol; 2022 Jun; 18(20):2475-2481. PubMed ID: 35535581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4.
    Hosoda W; Chianchiano P; Griffin JF; Pittman ME; Brosens LA; Noë M; Yu J; Shindo K; Suenaga M; Rezaee N; Yonescu R; Ning Y; Albores-Saavedra J; Yoshizawa N; Harada K; Yoshizawa A; Hanada K; Yonehara S; Shimizu M; Uehara T; Samra JS; Gill AJ; Wolfgang CL; Goggins MG; Hruban RH; Wood LD
    J Pathol; 2017 May; 242(1):16-23. PubMed ID: 28188630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosquamous carcinoma of the pancreas: preoperative diagnosis and molecular alterations.
    Murakami Y; Yokoyama T; Yokoyama Y; Kanehiro T; Uemura K; Sasaki M; Morifuji M; Sueda T
    J Gastroenterol; 2003; 38(12):1171-5. PubMed ID: 14714256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking the Clonal Evolution of Adenosquamous Carcinoma, a Rare Variant of Intraductal Papillary Mucinous Neoplasm of the Pancreas.
    Matsuzaka S; Karasaki H; Ono Y; Ogata M; Oikawa K; Tamakawa S; Chiba S; Muraki M; Yokochi T; Funakoshi H; Kono T; Nagashima K; Mizukami Y
    Pancreas; 2016 Jul; 45(6):915-8. PubMed ID: 27295533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.
    Witkiewicz AK; McMillan EA; Balaji U; Baek G; Lin WC; Mansour J; Mollaee M; Wagner KU; Koduru P; Yopp A; Choti MA; Yeo CJ; McCue P; White MA; Knudsen ES
    Nat Commun; 2015 Apr; 6():6744. PubMed ID: 25855536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma.
    Zhao X; Li H; Lyu S; Zhai J; Ji Z; Zhang Z; Zhang X; Liu Z; Wang H; Xu J; Fan H; Kou J; Li L; Lang R; He Q
    Int J Biol Sci; 2021; 17(10):2590-2605. PubMed ID: 34326696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosquamous carcinoma of the pancreas: a distinct clinicopathologic entity.
    Trikudanathan G; Dasanu CA
    South Med J; 2010 Sep; 103(9):903-10. PubMed ID: 20697320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of the proliferative ability of the squamous component regarding tumor progression of adenosquamous carcinoma of the pancreas: A preliminary report.
    Hoshimoto S; Hoshi N; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hirabayashi K; Ogata Y
    Pancreatology; 2017; 17(5):788-794. PubMed ID: 28784574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases.
    Kardon DE; Thompson LD; Przygodzki RM; Heffess CS
    Mod Pathol; 2001 May; 14(5):443-51. PubMed ID: 11353055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative outcomes of adenosquamous carcinoma of the pancreas: An analysis of the National Cancer Database.
    Hester CA; Augustine MM; Choti MA; Mansour JC; Minter RM; Polanco PM; Porembka MR; Wang SC; Yopp AC
    J Surg Oncol; 2018 Jul; 118(1):21-30. PubMed ID: 29878370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic characteristics of pancreatic squamous cell carcinoma, an investigation by using high throughput sequencing after in-solution hybrid capture.
    Xu MD; Liu SL; Feng YZ; Liu Q; Shen M; Zhi Q; Liu Z; Gu DM; Yu J; Shou LM; Gong FR; Zhu Q; Duan W; Chen K; Zhang J; Wu MY; Tao M; Li W
    Oncotarget; 2017 Feb; 8(9):14620-14635. PubMed ID: 28099906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review.
    Borazanci E; Millis SZ; Korn R; Han H; Whatcott CJ; Gatalica Z; Barrett MT; Cridebring D; Von Hoff DD
    World J Gastrointest Oncol; 2015 Sep; 7(9):132-40. PubMed ID: 26380056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing.
    Ma H; Song B; Guo S; Li G; Jin G
    Cancer Biomark; 2020; 27(3):389-397. PubMed ID: 31958074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The origins and consequences of
    Polaski JT; Udy DB; Escobar-Hoyos LF; Askan G; Leach SD; Ventura A; Kannan R; Bradley RK
    Elife; 2021 Jan; 10():. PubMed ID: 33404013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
    Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
    Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of chromosome 9p21 is associated with a poor prognosis in adenosquamous carcinoma of the pancreas.
    Jiang Y; Wu Y; Zhang L; Wang Y; Xu G; Deng Y; Han L; Li E; Ma Q; Xu M; Wu Z; Wang Z
    Precis Clin Med; 2023 Dec; 6(4):pbad030. PubMed ID: 38024139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.